(Q43475498)

English

Association between urinary albumin excretion and low-density lipoprotein heterogeneity following treatment of type 2 diabetes patients with the dipeptidyl peptidase-4 inhibitor, vildagliptin: a pilot study

scientific article published in December 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Association between urinary albumin excretion and low-density lipoprotein heterogeneity following treatment of type 2 diabetes patients with the dipeptidyl peptidase-4 inhibitor, vildagliptin: a pilot study (English)

1 reference

Europe PubMed Central

23 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Shigemasa Tani

1

1 reference

Europe PubMed Central

23 November 2017

Ken Nagao

2

1 reference

Europe PubMed Central

23 November 2017

Atsushi Hirayama

3

1 reference

Europe PubMed Central

23 November 2017

publication date

1 December 2013

1 reference

Europe PubMed Central

23 November 2017

American journal of cardiovascular drugs

1 reference

Europe PubMed Central

23 November 2017

13

1 reference

Europe PubMed Central

23 November 2017

6

1 reference

Europe PubMed Central

23 November 2017

443-450

1 reference

Europe PubMed Central

23 November 2017

https://scigraph.springernature.com/pub.10.1007/s40256-013-0043-2

0 references

Cardiovascular biology of the incretin system

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Chronic kidney disease: effects on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Microalbuminuria and coronary heart disease in NIDDM: an incidence study.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Cardiorenal syndrome: new perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Measurement of small dense low-density lipoprotein particles

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

The effect of vildagliptin therapy on atherogenic postprandial remnant particles and LDL particle size in subjects with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Mechanisms of glomerular albumin filtration and tubular reabsorption

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Sitagliptin reduces albuminuria in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Fluvastatin improves endothelial dysfunction in overweight postmenopausal women through small dense low-density lipoprotein reduction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-013-0043-2

21 January 2018

Identifiers

10.1007/S40256-013-0043-2

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43475498&oldid=1989632997"